The Nasdaq Composite broke out to fresh record highs this week, with broad-based strength across technology and semiconductor stocks powering the advance. Taiwan Semiconductor Manufacturing Company (TSMC), Nvidia, Tesla, and Elon Musk's SpaceX were among the names driving the rally, according to Investor's Business Daily. The move marks a notable moment of market confidence heading into October.
**TSMC Breaks Out on "Terafab" Chatter**
Taiwan Semiconductor was singled out as IBD's Stock of the Day on Monday, October 6, with the stock breaking out amid growing discussion around so-called "Terafab" developments — a term circulating in the semiconductor industry that appears tied to next-generation chip fabrication capacity and ambitions. The specifics of what Terafab refers to remain in early-stage discussion, but the market's reaction suggests investors are paying close attention to any signals about the future of large-scale chip manufacturing.
TSMC's central role in the global semiconductor supply chain makes it a closely watched bellwether. When the stock moves, it often reflects broader sentiment about the health of the chip industry and technology spending generally. Its appearance in the Nasdaq's record-high session alongside Nvidia underscores how much of the current market momentum is concentrated in companies tied to advanced computing and artificial intelligence infrastructure.
**Cancer Drug News Sends an AbbVie Partner Sharply Higher**
Not all of the week's action was in tech. An AbbVie partner company saw its stock surge after news broke concerning a cancer drug candidate described as a "$3 billion contender." The drug appears to be in a competitive oncology space, and the positive development — which IBD reported on Monday afternoon — was enough to send the partner stock flying. AbbVie itself is one of the largest pharmaceutical companies in the world, and its pipeline partnerships tend to attract significant investor attention whenever clinical or regulatory milestones are reached.
The move is a reminder that while technology is dominating the headline narrative, healthcare and biotech stocks remain capable of dramatic single-day moves when drug news hits.
**Shopify and Guardant Health Also in Focus**
IBD also highlighted Shopify and Guardant Health as stocks worth watching during Monday's session. Shopify, the e-commerce platform, has remained on traders' radar as a bellwether for consumer internet spending. Guardant Health operates in the liquid biopsy and cancer detection space — an area of oncology that has attracted both scientific and investor interest in recent years as non-invasive cancer screening technology advances.
The presence of both names in the same session as TSMC and Nvidia illustrates how this week's rally had some breadth beyond pure semiconductor exposure.
**A Limping IPO Market With a Potential Catalyst**
One area of the market that has not been sharing in the celebration is the IPO market. According to IBD, the initial public offering pipeline has been sluggish — but a specific upcoming offering is being described as something that could change the mood. The publication did not name the company in the headlines reviewed, but characterized it as a potentially significant event for a market that has been searching for momentum.
The IPO market has had a complicated few years. After a frenetic period of new listings earlier in the decade, rising interest rates and valuation resets cooled appetite considerably. A genuine breakout listing — one that prices well, trades well on debut, and sustains its gains — can shift sentiment and encourage other companies waiting in the wings to move forward with their own offerings.
IBD's IPO Leaders screen, which applies screening criteria focused on strong fundamental and technical traits among newer public companies, remains a tool investors use to track which recent IPOs are showing the kind of earnings growth and fund buying that have historically preceded strong stock performance.
**What's Driving the Broader Rally**
Markets are being buoyed by a combination of factors visible in the week's trading. Semiconductor optimism, driven by AI-related demand and supply chain investment, is clearly a dominant theme. Healthcare news flow is providing sporadic bursts of energy in biotech. And institutional fund activity — large mutual funds building stakes in highly rated companies — continues to be a mechanism that market watchers track as a sign of where professional money is flowing.
The Dow Jones Industrial Average futures also moved higher in after-hours trading following Monday's session, suggesting the bullish mood extended beyond the close.
For now, the Nasdaq's move to record territory is the headline. Whether that level holds — and whether the IPO market picks up meaningfully alongside it — will be worth watching in the sessions ahead.